Salus IRB

An expert partner in human subjects research administration.

Salus IRB Logo

Established in 1985, Salus IRB has been a reliable partner of the research enterprise, delivering an exceptional level of service and expertise while upholding the highest standards in human research protection. As an AAHRPP-accredited, unbiased, non-profit IRB, Salus IRB employs a consultative approach when working with sponsors and investigators.

Salus offers single-site, multi-site (single IRB/central IRB) and international research review services, with industry-leading response times and deep expertise in oncology and social, behavioral and educational research (SBER) studies.

Salus IRB provides dedicated review and support for research sponsors, institutions, and investigators. Existing Salus clients who need quick assistance can reach our team directly using the contact information below.

Contact Salus IRB:

 

Pearl IRB and Salus IRB Merger Announcement

Effective January 1, 2027, Pearl IRB will merge with Salus IRB as part of Versiti Clinical Trial Solutions (VCTS). 

By bringing our teams together, we will continue providing ethical regulatory review and personalized service to support your research.

Calendar

Key Dates and Deadlines

November 24th: Last day to submit new protocols or major protocol amendments to the Pearl IRB Manager submission platform
Prior to December 9th: Download any documents from IRB Manager as a backup.
December 8th: Last day to submit continuing reviews that are due and minor protocol amendments.
December 9th - December 14th:  The Pearl IRB Manager submission platform will not be accessible due to the data migration.
December 15th: The new integrated Salus IRB Manager submission platform will be available for all submissions.

What does this mean for your studies?

No action is required at this time. Existing studies will automatically transfer to Salus IRB's IRB Manager system. We will email clients additional information as the transition progresses. Please refer to the Pearl IRB + Salus IRB Merger FAQ for additional support.

Learn more about Salus IRB

Planning an upcoming study or have questions about how we can support your research?

Connect with the Versiti Clinical Trial Solutions team..

 

About Salus IRB

Salus IRB offers expert review of phase I-IV clinical trials and SBER studies with a group of board members spanning a wide range of therapeutic areas.
Learn More
 

Salus IRB Services

Institutional review board Salus IRB provides single-site, multi-site (single IRB/central IRB), and international review services for clinical trials.
Learn More
 

Salus IRB Forms and Resources

In certain situations, minimal-risk research might be eligible for IRB exemption. Salus IRB offers initial research review services to assess exemption eligibility.
Learn More
 

Partner with Salus IRB

Contact Salus IRB for assistance with research ethics, compliance, and protocol submissions. Find contact details and resources to support your research needs.
Learn More
 

Meet the Salus IRB Leadership Team

Meet the Salus IRB leadership team: dedicated experts guiding ethical research, participant safety, and compliance with the highest standards of integrity.
Learn More
 

Conferences and Events

The Versiti Clinical Trials team attends a number of events and conferences throughout the year to showcase our expertise in the clinical trial sphere.
Learn More